NEW YORK, July 1 (GenomeWeb News) - The National Cancer Institute's Board of Scientific Advisors has approved a five-year, $104 million budget for a new program aimed at optimizing current proteomic technologies.
Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.
